Crinetics Pharmaceuticals, Inc.
DelistedCIK 1658247fmd_0M2WWP3Y963F8F7HZX07025QB5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2026, 39 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 2 | 2 | 1 | 0 | 1 | 5 | 4 | 1 | 8 |
| Cost of revenue | – | – | – | – | – | – | – | 0 | 0 | 1 |
| Gross profit | – | – | – | – | – | – | – | 4 | 1 | 7 |
| Research and development | 5 | 9 | 24 | 42 | 57 | 84 | 130 | 169 | 240 | 332 |
| Selling, general and administrative | – | – | – | – | – | – | – | 58 | 100 | 191 |
| Total operating expenses | 7 | 11 | 31 | 55 | 75 | 109 | 173 | 227 | 340 | – |
| Operating income | (6) | (9) | (29) | (54) | (75) | (108) | (168) | (223) | (339) | (517) |
| Interest expense | 0 | 0 | – | – | – | – | – | – | – | – |
| Interest and investment income | 0 | 0 | 2 | 3 | 1 | 0 | 4 | 13 | 41 | 52 |
| Other non-operating income (expense) | 0 | (0) | 2 | 3 | 1 | 0 | 5 | 13 | 41 | 52 |
| Income before taxes | (6) | (9) | (27) | (50) | (74) | (108) | (164) | (209) | (298) | (465) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (6) | (9) | (27) | (50) | (74) | (108) | (164) | (209) | (298) | (465) |
| Net income | (6) | (9) | (27) | (50) | (74) | (108) | (164) | (215) | (298) | (465) |